nach oben

International Urogynecology Journal

Erschienen in:

01.10.2006 | Review Article

Estrogen therapy and urinary incontinence: what is the evidence and what do we tell our patients?

verfasst von: L. Elaine Waetjen, Peter L. Dwyer

Erschienen in: International Urogynecology Journal | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Excerpt

Loss of estrogen associated with menopause has been considered as a factor responsible for the increasing urinary incontinence prevalence in women as they age. Indeed, incontinence is commonly categorized as a symptom of urogenital atrophy. The presence of alpha and beta estrogen receptors throughout the urogenital tract suggests that estrogen has a role in the continence mechanism, and many observational studies have supported positive physiological effects. Estrogen has been shown to increase urethral closure pressure [1‐3], increase urethral blood flow [4], increase alpha-adrenergic receptor sensitivity [5, 6], and improve cellular maturation in both the urethra and vagina [7]. Based on these observational studies and a few clinical trials [8], medical management of urinary incontinence in postmenopausal women has included the use of both systemic and vaginal estrogen. …

Fantl JA, Cardozo L, McClish DK (1994) Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 83(1):12–18PubMed

Elia G, Bergman A (1993) Estrogen effects on the urethra: beneficial effects in women with genuine stress incontinence. Obstet Gynecol Surv 48(7):509–517PubMedCrossRef

Sacco F, Rigon G, Carbone A, Sacchini D (1990) Transvaginal estrogen therapy in urinary stress incontinence. Minerva Ginecol 42(12):539–544PubMed

Jarmy-Di Bella ZI, Girao MJ, Sartori MF et al (2000) Power Doppler of the urethra in continent or incontinent, pre- and postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct 11(3):148–154, Discussion 154–145PubMedCrossRef

Beisland HO, Fossberg E, Moer A, Sander S (1984) Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation. Urol Int 39(4):211–216PubMedCrossRef

Creed KE (1983) Effect of hormones on urethral sensitivity to phenylephrine in normal and incontinent dogs. Res Vet Sci 34(2):177–181PubMed

Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L (1998) Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstetrics and Gynecology 92:722–727PubMedCrossRef

Moehrer B, Hextall A, Jackson S (2003) Oestrogens for urinary incontinence in women (Cochrane Review). Cochrane Database Syst Rev (2):CD001405PubMed

Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T (2001) Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 97(1):116–120PubMedCrossRef

10.

Hendrix SL, Cochrane BB, Nygaard IE et al (2005) Effects of estrogen with and without progestin on urinary incontinence. JAMA 293(8):935–948PubMedCrossRef

11.

Steinauer JE, Waetjen LE, Vittinghoff E et al (2005) Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol 106(5):940–945PubMed

12.

Gebhardt J, Richard D, Barrett T (2001) Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am J Obstet Gynecol 185:1325–1330CrossRef

13.

Copas P, Bukovsky A, Asbury B, Elder RF, Caudle MR (2001) Estrogen, progesterone, and androgen receptor expression in levator ani muscle and fascia. J Womens Health Gend Based Med 10(8):785–795PubMedCrossRef

14.

Smith P, Heimer G, Norgren A, Ulmsten U (1990) Steroid hormone receptors in pelvic muscles and ligaments in women. Gynecol Obstet Investig 30(1):27–30CrossRef

15.

Fu X, Rezapour M, Wu X, Li L, Sjogren C, Ulmsten U (2003) Expression of estrogen receptor-alpha and -beta in anterior vaginal walls of genuine stress incontinent women. Int Urogynecol J Pelvic Floor Dysfunct 14(4):276–281, discussion 281PubMedCrossRef

16.

Zoubina EV, Smith PG (2003) Expression of estrogen receptors alpha and beta by sympathetic ganglion neurons projecting to the proximal urethra of female rats. J Urol 169(1):382–385, JanPubMedCrossRef

17.

Keane DP, Sims TJ, Abrams P, Bailey AJ (1997) Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Br J Obstet Gynaecol 104(9):994–998PubMed

18.

Falconer C, Ekman-Ordeberg G, Blomgren B et al (1998) Paraurethral connective tissue in stress-incontinent women after menopause. Acta Obstet Gynecol Scand 77(1):95–100PubMed

19.

Jackson S, James M, Abrams P (2002) The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. BJOG 109(3):339–344PubMedCrossRef

20.

Aikawa K, Sugino T, Matsumoto S, Chichester P, Whitbeck C, Levin RM (2003) The effect of ovariectomy and estradiol on rabbit bladder smooth muscle contraction and morphology. J Urol 170:634–637PubMedCrossRef

21.

Sartori MG, Girao MJ, de Jesus Simoes M, Sartori JP, Baracat EC, Rodrigues de Lima G (2001) Quantitative evaluation of collagen and muscle fibers in the lower urinary tract of castrated and under-hormone replacement female rats. Clin Exp Obstet Gynecol 28(2):92–96PubMed

22.

Fleischmann N, Christ G, Sclafani T, Melman A (2002) The effect of ovariectomy and long-term estrogen replacement on bladder structure and function in the rat. J Urol 168(3):1265–1268PubMedCrossRef

23.

Endo RM, Girao MJ, Sartori MG, Simoes MJ, Baracat EC, Rodrigues de Lima G (2000) Effect of estrogen–progestogen hormonal replacement therapy on periurethral and bladder vessels. Int Urogynecol J Pelvic Floor Dysfunct 11(2):120–123PubMed

24.

Robinson D, Rainer RO, Washburn SA, Clarkson TB (1996) Effects of estrogen and progestin replacement on the urogenital tract of the ovariectomized cynomolgus monkey. Neurourol Urodyn 15(3):215–221PubMedCrossRef

25.

Zoubina EV, Mize AL, Alper RH, Smith PG (2001) Acute and chronic estrogen supplementation decreases uterine sympathetic innervation in ovariectomized adult virgin rats. Histol Histopathol 16(4):989–996PubMed

26.

Hendrix SL, McNeeley SG (2001) Effect of selective estrogen receptor modulators on reproductive tissues other than endometrium. Ann N Y Acad Sci 949:243–250PubMedCrossRef

27.

Waetjen LE, Brown JS, Modelska K, Blackwell T, Vittinghoff E, Cummings SR (2004) Effect of raloxifene on urinary incontinence: a randomized controlled trial. Obstet Gynecol 103(2):261–266PubMed

28.

Samsioe G, Jansson I, Mellstrom D, Svanborg A (1985) Occurrence, nature and treatment of urinary incontinence in a 70-year-old female population. Maturitas 7(4):335–342PubMedCrossRef

29.

Rufford J, Hextall A, Cardozo L, Khullar V (2003) A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct 14(2):78–83PubMedCrossRef

30.

Grodstein F, Lifford K, Resnick NM, Curhan GC (2004) Postmenopausal hormone therapy and risk of developing urinary incontinence. Obstet Gynecol 103(2):254–260PubMed

31.

Waetjen LE, Brown JS, Vittinghoff E et al (2005) The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women. Obstet Gynecol 106(5):946–952PubMed

32.

Henalla SM, Millar DR, Wallace KJ (1990) Surgical versus conservative management for post-menopausal genuine stress incontinence of urine (abstract).Neurourol Urodyn 9(4):436–437

33.

Cardozo LD, Wise BG, Benness CJ (2001) Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal women—a double-blind placebo-controlled study. J Obstet Gynaecol 21(4):383–385PubMedCrossRef

34.

Enzelsberger H, Kurz C, Schatten C, Huber J (1991) The effectiveness of intravaginal estriol tablet administration in women with urge incontinence. Geburtshilfe Frauenheilkd 51(10):834–838PubMed

35.

Assassa RP, Jagger C, Williams K, McGrother C, Mayne C (2003) Randomised double-blind placebo controlled trial of topical oestrogen in the treatment of female bladder symptoms. Int Urogynecol J 14(Suppl 1):S43

36.

Cardozo L, Rekers H, Tapp A et al (1993) Oestriol in the treatment of postmenopausal urgency: a multicentre study. Maturitas 18(1):47–53PubMedCrossRef

37.

Jackson S, Shepherd A, Brookes S, Abrams P (1999) The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial. Br J Obstet Gynaecol 106(7):711–718PubMed

38.

Hextall A, Bidmead J, Cardozo L, Hooper R (2001) The impact of the menstrual cycle on urinary symptoms and the results of urodynamic investigation. Bjog 108(11):1193–1196PubMedCrossRef

39.

Raz S, Zeigler M, Caine M (1973) The effect of progesterone on the adrenergic receptors of the urethra. Br J Urol 45(2):131–135PubMedCrossRef

40.

Ouslander JG, Greendale GA, Uman G, Lee C, Paul W, Schnelle J (2001) Effects of oral estrogen and progestin on the lower urinary tract among female nursing home residents. J Am Geriatr Soc 49(6):803–807PubMedCrossRef

41.

Goldstein SR, Johnson S, Watts NB, Ciaccia AV, Elmerick D, Muram D (2005) Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen. Menopause 12(2):160–164PubMedCrossRef

42.

Wilson PD, Faragher B, Butler B, Bu’Lock D, Robinson EL, Brown AD (1987) Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women. Br J Obstet Gynaecol 94(6):568–574PubMed

Titel: Estrogen therapy and urinary incontinence: what is the evidence and what do we tell our patients?
verfasst von: L. Elaine Waetjen
Peter L. Dwyer
Publikationsdatum: 01.10.2006
Verlag: Springer-Verlag
Erschienen in: International Urogynecology Journal / Ausgabe 5/2006
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-006-0080-3

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Estrogen therapy and urinary incontinence: what is the evidence and what do we tell our patients?

Excerpt

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2006

Botox in urology

Safety and effectiveness of Colpexin Sphere in the treatment of pelvic organ prolapse

Functional and histological effects of intravaginal electrical stimulation on the pelvic muscles: a study in the rat

Peripartum urinary incontinence in a racially diverse obstetrical population

Inflammatory reaction following bovine pericardium graft augmentation for posterior vaginal wall defect repair

Inflammatory response to bovine pericardium: reply to letter by Davila

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie